We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Mechanistic involvement of the calpain-calpastatin system in Alzheimer neuropathology.
- Authors
Higuchi, Makoto; Iwata, Nobuhisa; Matsuba, Yukio; Takano, Jiro; Suemoto, Takahiro; Maeda, Jun; Ji, Bin; Ono, Maiko; Staufenbiel, Matthias; Suhara, Tetsuya; Saido, Takaomi C.
- Abstract
The mechanism by which amyloid-β peptide (Aβ) accumulation causes neurodegeneration in Alzheimer's disease (AD) remains unresolved. Given that Aβ perturbs calcium homeostasis in neurons, we investigated the possible involvement of calpain, a calcium-activated neutral protease. We first demonstrated close postsynaptic association of calpain activation with Aβ plaque formation in brains from both patients with AD and transgenic (Tg) mice overexpressing amyloid precursor protein (APP). Using a viral vector-based tracer, we then showed that axonal termini were dynamically misdirected to calpain activation-positive Aβ plaques. Consistently, cerebrospinal fluid from patients with AD contained a higher level of calpain-cleaved spectrin than that of controls. Genetic deficiency of calpastatin (CS), a calpain-specific inhibitor protein, augmented Aβ amyloidosis, tau phosphorylation, microgliosis, and somatodendritic dystrophy, and increased mortality in APP-Tg mice. In contrast, brain-specific CS overexpression had the opposite effect. These findings implicate that calpain activation plays a pivotal role in the Aβ-triggered pathological cascade, highlighting a target for pharmacological intervention in the treatment of AD.
- Subjects
PEPTIDES; ALZHEIMER'S disease; CALPAIN; CYSTEINE proteinases; PROTEIN precursors
- Publication
FASEB Journal, 2012, Vol 26, Issue 3, p1204
- ISSN
0892-6638
- Publication type
Article
- DOI
10.1096/fj.11-187740